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Materials and Methods  
Unless otherwise stated, reactions were performed in flame-dried glassware under an argon or 
nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried by passage through 
an activated alumina column under argon. Reaction progress was monitored by thin-layer 
chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was performed using E. Merck silica 
gel 60 F254 precoated glass plates (0.25 mm) and visualized by UV fluorescence quenching, p-
anisaldehyde, or KMnO4 staining.  Silicycle SiliaFlash® P60 Academic Silica gel (particle size 
40–63 nm) was used for flash chromatography. The (Z)-enol carbonates were purified by 
preparative LC on a Teledyne Isco ACCQPrep HP125; column: C–18, 100 Å, 5 µm, ID 20 mm. 
1H NMR spectra were recorded on Varian Inova 500 MHz and Bruker 400 MHz spectrometers 
and are reported relative to residual CHCl3 (δ 7.26 ppm).  13C NMR spectra were recorded on a 
Varian Inova 500 MHz spectrometer (125 MHz) and Bruker 400 MHz spectrometers (100 MHz) 
and are reported relative to CHCl3 (δ 77.16 ppm). Data for 1H NMR are reported as follows: 
chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration).  Multiplicities are 
reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, 
m = multiplet, br s = broad singlet, br d = broad doublet.  Data for 13C NMR are reported in 
terms of chemical shifts (δ ppm).  IR spectra were obtained by use of a Perkin Elmer Spectrum 
BXII spectrometer or Nicolet 6700 FTIR spectrometer using thin films deposited on NaCl plates 
and reported in frequency of absorption (cm–1).  Optical rotations were measured with a Jasco P-
2000 polarimeter operating on the sodium D-line (589 nm), using a 100 mm path-length cell.  
High resolution mass spectra (HRMS) were obtained from Agilent 6200 Series TOF with an 
Agilent G1978A Multimode source in electrospray ionization (ESI+), atmospheric pressure 
chemical ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+). Reagents were 
purchased from commercial sources and used as received unless otherwise stated.  
List of Abbreviations: 
ee – enantiomeric excess, SFC – supercritical fluid chromatography, TLC – thin-layer 
chromatography, IPA – isopropanol 
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General Procedure for Overman Rearrangement 
 
To a stirred solution of the alcohol 2 (0.2 mmol, 1.0 equiv) in THF (1 mL) at –78 ºC under a 
nitrogen atmosphere was added slowly a solution of LiHMDS (40 mg, 0.24 mmol, 1.2 equiv) in 
THF (1 mL).  The mixture was stirred at –78 °C for 30 min before adding a solution of (E)-2,2,2-
trifluoro-N-(4-methoxyphenyl)acetimidoyl chloride1 (62 mg, 0.26 mmol, 1.3 equiv) in THF (1 
mL).  The reaction was allowed to reach room temperature and stirred for 30 min.  The reaction 
was then filtered through a silica plug (pretreated with Et3N) eluting with 10% Et3N in Et2O.  
Following solvent removal in vacuo the crude residue was dissolved in 2 mL of xylenes and 
K2CO3 (28 mg, 0.2 mmol, 1.0 equiv) was added.  The reaction was then heated to 130 ºC for 18 
h, allowed to cool to ambient temperature, and directly purified by silica gel column 
chromatography to provide the desired product.  
 
(S)-N-(6-bromo-3,4-dihydro-[1,1'-biphenyl]-1(2H)-yl)-2,2,2-trifluoro-N-(4-
methoxyphenyl)acetamide (3a) 
Purified by column chromatography (10% EtOAc in Hexanes) to provide the desired product as 
an amorphous white solid (41 mg, 45% yield); 96% ee, [α]D25 181.7 (c 0.70, CHCl3); 1H NMR 
(500 MHz, Chloroform-d) δ 7.21 (m, 6H), 7.00 (dd, J = 8.9, 2.6 Hz, 1H), 6.80 (dd, J = 8.7, 3.0 
Hz, 1H), 6.60 (dd, J = 8.8, 3.0 Hz, 1H), 6.51 (dd, J = 4.9, 3.1 Hz, 1H), 3.77 (s, 3H), 2.88 (d, J = 
12.0 Hz, 1H), 2.35 (d, J = 10.1 Hz, 1H), 2.28 – 2.17 (m, 1H), 2.12 – 2.01 (m, 1H), 1.66 – 1.56 
(m, 1H), 1.31 – 1.18 (m, 1H); 13C NMR (100 MHz, Chloroform-d) δ 159.7, 156.6 (q, J = 34.5 
Hz), 139.7, 136.0, 132.4, 132.4, 129.6, 128.3, 127.7, 127.2, 124.1, 116.3 (q, J = 289.8 Hz), 
113.6, 112.8, 73.1, 55.4, 35.5, 27.62, 18.5; 19F NMR (282 MHz, Chloroform-d) δ –67.1; IR (Neat 
film, NaCl) 3443, 2931, 1697, 1509, 1250, 1200, 1177, 1035, 760, 732, 698 cm–1; HRMS (MM: 
OH
Br
R
2
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ESI-APCI+) m/z calc’d for C21H20BrF3NO2 [M+H]+: 454.0629, found 454.0605; SFC conditions: 
10% IPA, Chiralpak OJ-H column, λ=210 nm, tR (min): minor = 4.68, major = 5.18. 
 
 
 
(S)-N-(1-allyl-2-bromocyclohex-2-en-1-yl)-2,2,2-trifluoro-N-(4-methoxyphenyl)acetamide 
(3b) 
Purified by column chromatography (5% Et2O in hexanes) to provide the desired product as a 
yellow solid (63 mg, 75% yield); 95% ee, [α]D25 124.0 (c 0.70, CHCl3);  1H NMR (400 MHz, 
Chloroform-d) δ 7.47 (d, J = 8.8 Hz, 1H), 7.10 (dd, J = 8.7, 2.7 Hz, 1H), 6.88 (ddd, J = 22.0, 8.7, 
3.0 Hz, 2H), 6.37 (dd, J = 5.8, 2.9 Hz, 1H), 5.53 – 5.39 (m, 1H), 5.00 – 4.92 (m, 2H), 3.85 (s, 
3H), 2.79 – 2.67 (m, 1H), 2.48 (dd, J = 13.7, 5.6 Hz, 1H), 2.41 – 2.25 (m, 1H), 2.19 – 2.02 (m, 
2H), 1.95 – 1.74 (m, 3H); 13C NMR (100 MHz, Chloroform-d) δ 160.2, 156.0 (q, J = 34.3 Hz), 
134.5, 133.0, 132.7, 132.3, 128.4, 124.9, 118.5, 116.1 (q, J = 289.5 Hz), 113.7, 113.5, 67.4, 55.5, 
44.0, 33.0, 26.9, 20.5; 19F NMR (282 MHz, Chloroform-d) δ –67.4; IR (Neat film, NaCl) 3076, 
2937, 3838, 1703, 1310, 1444, 1252, 1201, 1152, 1032, 922, 838, 739 cm-1; HRMS (MM: ESI-
N CF3
O
OMe
Br
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APCI+) m/z calc’d for C18H20BrF3NO2 [M+H]+: 418.0629, found 418.0609 ; SFC conditions: 5% 
IPA, Chiralpak OJ-H column, λ=210 nm, tR (min): minor = 3.26, major = 3.79. 
 
 
 
Procedure for Preparatory Scale Preparation of 3b 
A solution of alcohol 2b (4.62 mmol, 1.0 g) dissolved in 23 mL of THF was cooled to –78 °C in 
a dry-ice/acetone bath.  A solution of LiHMDS (6.06 mmol, 1.440 g) in 20 mL THF was then 
added slowly, and the resulting mixture stirred at –78 °C for 30 min.  A solution of (E)-2,2,2-
trifluoro-N-(4-methoxyphenyl)acetimidoyl chloride in 10 mL of THF was then added slowly, 
and the reaction allowed to slowly warm to room temperature and continued for 30 min.  The 
crude reaction mixture was then filtered through a short silica plug (pretreated with Et3N) eluting 
10% Et3N in Et2O.  Following solvent removal in vacuo, the crude residue was redissolved in 20 
mL xylenes and K2CO3 (4.62 mmol, 637 mg) was added.  The reaction was then heated to 130 
°C for 18 h, allowed to cool to ambient temperature, and directly purified by silica gel column 
chromatography (5% Et2O in hexanes) to provide the desired product as a yellow solid (1.6 g, 
83% yield) 
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(R)-N-(2-bromo-1-ethylcyclohex-2-en-1-yl)-2,2,2-trifluoro-N-(4-methoxyphenyl)acetamide 
(3c) 
Purified by column chromatography (10% Et2O in hexanes) to provide the desired product as a 
brown oil (69 mg, 85% yield); 96% ee, [α]D25 137.3 (c 0.70, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.44 (ddd, J = 8.8, 2.6, 1.2 Hz, 1H), 7.08 (dd, J = 8.7, 2.7 Hz, 1H), 6.89 (dd, J = 
8.8, 3.0 Hz, 1H), 6.83 (dd, J = 8.7, 3.0 Hz, 1H), 6.40 (dd, J = 5.6, 3.1 Hz, 1H), 3.84 (s, 3H), 2.73 
(dddd, J = 13.2, 11.8, 4.6, 1.2 Hz, 1H), 2.42 – 2.33 (m, 1H), 2.16 – 2.05 (m, 2H), 1.91 (dp, J = 
14.1, 5.0 Hz, 1H), 1.81 – 1.60 (m, 2H), 1.27 – 1.17 (m, 1H), 0.75 (t, J = 7.5 Hz, 3H); 13C NMR 
(100 MHz, Chloroform-d) δ 160.0, 156.1 (q, J = 34.2 Hz), 135.0, 132.8, 132.3, 128.5, 125.0, 
116.2 (q, J = 289.8 Hz), 113.6, 113.2, 68.2, 55.4, 32.8, 32.5, 26.9, 21.2, 9.4; 19F NMR (282 MHz, 
Chloroform-d) δ –67.3; IR (Neat film, NaCl) 3390, 2970, 2941, 2838, 1703, 1697, 1505, 1252, 
1200, 1179, 1166, 1033, 839, 800, 736, 680, 625 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
C17H20BrF3NO2 [M+H]+: 406.0629, found 406.0632;  SFC conditions: 3% IPA, Chiralpak AD-H 
column, λ=210 nm, tR (min): minor = 6.03, major = 6.58. 
 
 
N CF3
O
OMe
Et
Br
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(R)-N-(2-bromo-1-methylcyclohex-2-en-1-yl)-2,2,2-trifluoro-N-(4-
methoxyphenyl)acetamide (3d) 
Purified by column chromatography (10% Et2O in hexanes) to provide the desired product as a 
colorless oil (75 mg, 95% yield); 97% ee, [α]D25 77.1 (c 0.50, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.51 (dd, J = 8.8, 2.7 Hz, 1H), 7.05 (dd, J = 8.7, 2.7 Hz, 1H), 6.91 (dd, J = 8.8, 
3.0 Hz, 1H), 6.85 (dd, J = 8.6, 3.0 Hz, 1H), 6.18 (dd, J = 6.5, 2.1 Hz, 1H), 3.84 (s, 3H), 2.86 – 
2.75 (m, 1H), 2.34 (dddd, J = 17.4, 11.8, 5.6, 2.4 Hz, 1H), 2.14 – 2.06 (m, 1H), 1.97 (dtd, J = 
12.4, 3.4, 1.6 Hz, 1H), 1.87 (dt, J = 10.0, 4.8 Hz, 1H), 1.80 – 1.67 (m, 1H), 1.04 (s, 3H); 13C 
NMR (100 MHz, Chloroform-d) δ 160.0, 155.8 (q, J = 34.6 Hz), 132.4, 131.7, 131.1, 128.7, 
127.2, 116.1 (q, J = 289.4 Hz), 113.7, 113.5, 66.3, 56.8, 33.5, 27.1, 26.1; 19F NMR (282 MHz, 
Chloroform-d) δ –67.7; IR (Neat film, NaCl) 3435m 2941, 2838, 1697, 1510, 1201, 1182, 1149, 
1032, 840, 738, 687 cm-1. HRMS (MM: ESI-APCI+) m/z calc’d for C16H18BrF3NO2 [M+H]+: 
392.0473, found 392.0450 ; SFC conditions: 10% IPA, Chiralpak OJ-H column, λ=210 nm, tR 
(min): minor = 3.41, major = 4.11. 
N CF3
O
OMe
Me
Br
Supporting Information for Velasco-Rubio, Alexy, Yoritate, Wright and Stoltz SI8	
 
  
 
  
(S)-N-(2-bromo-1-phenethylcyclohex-2-en-1-yl)-2,2,2-trifluoro-N-(4-
methoxyphenyl)acetamide (3e) 
Purified by column chromatography (Et2O 10% in hexanes) to provide the desired product as a 
yellow foam (68 mg, 70% yield); 97 % ee, [α]D25 123.2 (c 0.70, CHCl3);  1H NMR (500 MHz, 
Chloroform-d) δ 7.43 (dd, J = 8.2, 2.1 Hz, 1H), 7.24 – 7.18 (m, 2H), 7.18 – 7.10 (m, 2H), 7.00 – 
6.94 (m, 2H), 6.93 – 6.86 (m, 1H), 6.83 (dd, J = 8.7, 3.0 Hz, 1H), 6.41 (dd, J = 5.5, 3.1 Hz, 1H), 
3.83 (s, 3H), 2.95 – 2.84 (m, 1H), 2.54 (td, J = 12.9, 3.8 Hz, 1H), 2.42 (dddd, J = 18.0, 9.1, 5.8, 
3.1 Hz, 1H), 2.31 – 2.13 (m, 4H), 1.96 (td, J = 13.4, 3.9 Hz, 2H), 1.90 – 1.70 (m, 2H); 13C NMR 
(100 MHz, Chloroform-d) δ 160.1, 156.2 (q, J = 34.4 Hz), 141.3, 134.9, 132.7, 132.6, 128.4, 
128.3, 126.0, 125.4, 116.2 (q, J = 289.8 Hz), 113.8, 113.3, 68.0, 55.5, 41.2, 32.2, 31.3, 27.1, 
20.8; 19F NMR (282 MHz, Chloroform-d) δ –67.2; IR (Neat film, NaCl) 3437, 2937, 1697, 1667, 
1643, 1509, 1454, 1251, 1201, 1178, 1165, 1149, 1031, 738, 690 cm-1; HRMS (MM: ESI-
N CF3
O
OMe
Br
Ph
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APCI+) m/z calc’d for C23H24BrF3NO2 [M+H]+: 482.0942, found 482.0953; SFC conditions: 20% 
IPA, Chiralpak OJ-H column, λ=210 nm, tR (min): minor = 2.80, major = 3.64. 
 
 
 
 
 
(S)-N-(2-bromo-1-(4-methylphenethyl)cyclohex-2-en-1-yl)-2,2,2-trifluoro-N-(4-
methoxyphenyl)acetamide (3f) 
Purified by column chromatography (Et2O 10% in hexanes) to provide the desired product as a 
off-white solid (70 mg, 70% yield); 97% ee, [α]D25 222.3 (c 0.70, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.43 (ddd, J = 8.8, 2.7, 1.1 Hz, 1H), 7.13 (dd, J = 8.2, 2.3 Hz, 1H), 7.02 (d, J = 
7.7 Hz, 2H), 6.90 – 6.81 (m, 4H), 6.40 (dd, J = 5.5, 3.1 Hz, 1H), 3.83 (s, 3H), 2.92 – 2.84 (m, 
1H), 2.54 – 2.37 (m, 2H), 2.29 (s, 3H), 2.26 – 2.14 (m, 3H), 2.01 – 1.69 (m, 4H); 13C NMR (100 
MHz, Chloroform-d) δ 160.1, 156.2 (q, J = 34.3 Hz), 138.3, 135.5, 134.8, 132.8, 132.6, 129.1, 
128.4, 128.2, 125.4, 116.2 (q, J = 289.8 Hz), 113.8, 113.3, 68.0, 55.5, 41.3, 32.2, 30.8, 27.1, 
N CF3
O
OMe
Br
Me
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20.8; 19F NMR (282 MHz, Chloroform-d) δ –67.2; IR (Neat film, NaCl) 3444, 2937, 1697, 1509, 
1198, 1178, 1151, 1164, 1033, 839, 736, 624 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
C24H26BrF3NO2 [M+H]+: 496.1099, found 496.1118; SFC conditions: 10% IPA, Chiralpak OJ-H 
column, λ = 210 nm, tR (min): minor = 6.47, major = 6.87. 
 
 
 
 
(S)-N-(2-bromo-1-(4-fluorophenethyl)cyclohex-2-en-1-yl)-2,2,2-trifluoro-N-(4-
methoxyphenyl)acetamide (3g) 
Purified by column chromatography (Et2O 10% in hexanes) to provide the desired product as an 
amorphous solid (75 mg, 75% yield); 97% ee, [α]D25 118.3 (c 0.70, CHCl3);  1H NMR (400 
MHz, Chloroform-d) δ 7.42 (dd, J = 8.7, 1.5 Hz, 1H), 7.13 (dd, J = 8.8, 2.8 Hz, 1H), 6.95 – 6.78 
(m, 6H), 6.41 (dd, J = 5.5, 3.1 Hz, 1H), 3.82 (s, 3H), 2.89 (ddd, J = 13.2, 11.4, 4.2 Hz, 1H), 2.57 
– 2.35 (m, 2H), 2.31 – 2.11 (m, 3H), 2.02 – 1.66 (m, 4H); 13C NMR (100 MHz, Chloroform-d) δ 
162.5, 160.1, 160.1, 156.2 (q, J = 34.3 Hz), 137.0, 136.9, 135.1, 132.7, 132.6, 129.7, 129.6, 
N CF3
O
OMe
Br
F
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128.3, 116.2 (q, J = 289.7 Hz), 115.3, 115.1, 113.8, 113.3, 68.0, 55.5, 41.4, 32.2, 30.5, 27.1, 
20.7; 19F NMR (282 MHz, Chloroform-d) δ –67.2, -116.1 – -118.8 (m); IR (Neat film, NaCl) 
3443, 2936, 1698, 1509, 1252, 1201, 1179, 1154, 1032, 970, 834, 736 cm-1; HRMS (MM: ESI-
APCI+) m/z calc’d for C23H23BrF4NO2 [M+H]+: 500.0848, found 500.0846; SFC conditions: 
10% IPA, Chiralpak OJ-H column, λ = 210 nm, tR (min): minor = 4.96, major = 5.98. 
 
 
 
 
(S)-N-(2-bromo-1-(4-methoxyphenethyl)cyclohex-2-en-1-yl)-2,2,2-trifluoro-N-(4-
methoxyphenyl)acetamide (3h) 
Purified by column chromatography (CH2Cl2 50% in hexanes) to provide the desired product as 
a colorless oil (62mg, 60% yield); 98% ee, [α]D25 85.2 (c 0.70, CHCl3); 1H NMR (400 MHz, 
Chloroform-d) δ 7.43 (dd, J = 8.8, 1.5 Hz, 1H), 7.12 (dd, J = 8.7, 2.7 Hz, 1H), 6.94 – 6.79 (m, 
4H), 6.79 – 6.70 (m, 2H), 6.40 (dd, J = 5.5, 3.0 Hz, 1H), 3.82 (s, 3H), 3.75 (s, 3H), 2.94 – 2.80 
N CF3
O
OMe
Br
OMe
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(m, 1H), 2.54 – 2.34 (m, 2H), 2.25 – 2.09 (m, 3H), 2.02 – 1.77 (m, 3H), 1.70 (td, J = 13.2, 4.9 
Hz, 1H); 13C NMR (100 MHz, Chloroform-d) δ 160.1, 157.9, 156.2 (q, J = 34.4 Hz), 134.8, 
133.4, 132.8, 132.6, 129.2, 128.4, 125.4, 116.2 (q, J = 289.8 Hz), 113.8, 113.3, 68.0, 55.5, 41.5, 
30.4, 20.8; 19F NMR (282 MHz, Chloroform-d) δ -67.2; IR (Neat film, NaCl) 3386, 2934, 2836, 
1697, 1513, 1249, 1201, 1178, 1151, 1034, 824, 737 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d 
for C24H26BrF3NO3 [M+H]+: 512.1048, found 512.1056; SFC conditions: 10% IPA, Chiralpak 
OJ-H column, λ = 210 nm, tR (min): minor = 10.76, major = 11.37. 
 
 
 
 
(S)-N-(2-bromo-1-(4-phenylbut-3-yn-1-yl)cyclohex-2-en-1-yl)-2,2,2-trifluoro-N-(4-
methoxyphenyl)acetamide (3i) 
Purified by column chromatography (15% Et2O in Hexanes) to provide the desired product as  a 
colorless oil (51 mg, 50% yield); 92% ee, [α]D25 181.7 (c 0.70, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.47 (ddd, J = 8.8, 3.0, 1.4 Hz, 1H), 7.36 – 7.30 (m, 2H), 7.27 (tq, J = 3.9, 2.1 
N CF3
O
OMe
Br
Ph
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Hz, 3H), 7.14 (dd, J = 8.7, 2.7 Hz, 1H), 6.94 (dd, J = 8.8, 3.0 Hz, 1H), 6.87 (dd, J = 8.7, 3.0 Hz, 
1H), 6.43 (dd, J = 5.5, 3.2 Hz, 1H), 3.86 (s, 3H), 2.84 (ddd, J = 13.4, 11.5, 4.4 Hz, 1H), 2.46 – 
2.30 (m, 2H), 2.24 – 2.12 (m, 3H), 2.06 (ddd, J = 13.5, 10.6, 5.1 Hz, 1H), 2.02 – 1.92 (m, 1H), 
1.92 – 1.70 (m, 2H); 13C NMR (101 MHz, Chloroform-d) δ 160.2, 156.2 (q, J = 34.4 Hz), 135.5, 
132.7, 132.4, 131.5, 128.2, 127.8, 124.5, 123.5, 116.2 (q, J = 289.7 Hz), 113.9, 113.5, 88.9, 80.8, 
67.5, 55.5, 55.4, 38.1, 32.3, 27.0, 20.7, 15.3; 19F NMR (282 MHz, Chloroform-d) δ -67.2; IR 
(Neat film, NaCl) 3441, 2937, 2839, 1703, 1698, 1510, 1300, 1252, 1200, 1179, 1152, 1032, 
972, 756, 690 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C25H24BrF3NO2 [M+H]+: 
506.0942, found 506.0962; SFC conditions: 15% IPA, Chiralpak AD-H column, λ = 210 nm, tR 
(min): minor = 4.51, major =4.98. 
 
 
 
 
 
General procedure A for the synthesis of the 2-bromo-enones 
 
 
To a solution of 2-bromo-3-ethoxycyclohex-2-en-1-one2 (1.09 g, 5 mmol, 1.0 equiv) in THF (0.1 
M) at 0 ºC was added slowly the corresponding Grignard (2.0 equiv).  The reaction was then 
O
OEt
Br  2 equiv. RMgBr
THF
0 ºC to 40 ºC
then HCl, rt
R
Br
O
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heated to 40 °C and continued until no starting material remained as seen by TLC.  The reaction 
was then quenched with 2M HCl (2.0 equiv) and stirred at room temperature for 2 hours.  The 
reaction was diluted with water and extracted with Et2O, and the combined organic phases dried 
over anhydrous Na2SO4 and concentrated. The crude product was purified by silica gel column 
chromatography to yield the desired product. 
 
 
2-bromo-5,6-dihydro-[1,1'-biphenyl]-3(4H)-one (1a) 
Purified by column chromatography (10% AcOEt in Hexanes) to provide a white-off solid (1 g, 
80% yield); 1H NMR (500 MHz, Chloroform-d) δ 7.46 – 7.29 (m, 5H), 2.79 (t, J = 6.0 Hz, 2H), 
2.75 – 2.69 (m, 2H), 2.21 – 2.13 (m, 2H); 13C NMR (100 MHz, Chloroform-d) δ 191.7, 160.8, 
140.8, 128.9, 128.4, 126.9, 122.5, 37.8, 35.1, 22.4; IR (Neat film NaCl) 3056, 2957, 2867, 1681, 
1588, 1265, 1182, 1130, 983, 785, 755, 700 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
C12H12BrO  [M+H]+: 251.0071, found 251.0069. 
 
 
 
 
3-allyl-2-bromocyclohex-2-en-1-one (1b) 
Purified by column chromatography (20% AcOEt in Hexanes) to provide a colorless oil (1.020 g, 
95% yield); 1H NMR (500 MHz, Chloroform-d) δ 5.78 (td, J = 16.8, 16.0, 7.4 Hz, 1H), 5.22 – 
5.14 (m, 2H), 3.24 (d, J = 6.7 Hz, 2H), 2.59 (t, J = 6.6 Hz, 2H), 2.50 (t, J = 6.0 Hz, 2H), 1.99 (p, 
J = 5.9 Hz, 2H); 13C NMR (100 MHz, Chloroform-d) δ 191.3, 161.0, 131.6, 123.1, 118.4, 43.4, 
37.8, 32.1, 21.9; IR (Neat film NaCl) 3079, 2949, 2888, 1693, 1598, 1453, 1427, 1416, 1273, 
1183, 985, 920, 794 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C9H12BrO [M+H]+: 
215.0071, found 215.0059. 
 
O
Br
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2-bromo-3-ethylcyclohex-2-en-1-one (1c) 
Purified by column chromatography (10% AcOEt in Hexanes) to provide a red oil (707 mg, 70% 
yield); 1H NMR (500 MHz, Chloroform-d) δ 2.60 – 2.54 (m, 2H), 2.54 – 2.41 (m, 4H), 2.04 – 
1.95 (m, 2H), 1.13 (t, J = 7.6 Hz, 3H); 13C NMR (100 MHz, Chloroform-d) δ 191.4, 165.3, 
122.0, 37.8, 32.5, 31.9, 22.0, 11.0; IR (Neat film NaCl) 3436, 2936, 2875, 1693, 1598, 1455k 
1461, 1282, 1191, 1170, 1133, 984, 886, 801 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
C8H12BrO [M+H]+: 203.0071, found 203.0060.  
 
 
2-bromo-3-methylcyclohex-2-en-1-one (1d) 
Purified by column chromatography (10% AcOEt in Hexanes) to provide the desired product a 
colorless oil (750 mg, 80% yield); 1H NMR (400 MHz, Chloroform-d) δ 2.58 – 2.45 (m, 4H), 
2.14 (t, J = 0.9 Hz, 3H), 2.02 – 1.90 (m, 2H); 13C NMR (101 MHz, Chloroform-d) δ 191.0, 
160.6, 122.7, 37.6, 34.2, 25.9, 21.8; IR (Neat film NaCl) 2946, 2869, 1681, 1605, 1452, 1426, 
1371, 1269, 1194, 1172, 1269, 1194, 1172, 1134, 1039, 978, 909, 793 cm-1; HRMS (MM: ESI-
APCI+) m/z calc’d for C7H10BrO  [M+H]+: 188.9915, found 188.9907. 
 
 
2-bromo-3-phenethylcyclohex-2-en-1-one (1e) 
Purified by column chromatography (20% AcOEt in Hexanes) to provide the desired product as 
a white solid (1.110 g, 80% yield); 1H NMR (500 MHz, Chloroform-d) δ 7.33 – 7.28 (m, 2H), 
7.25 – 7.21 (m, 3H), 2.92 – 2.85 (m, 2H), 2.83 – 2.74 (m, 2H), 2.62 – 2.53 (m, 2H), 2.39 (t, J = 
6.1 Hz, 2H), 1.99 – 1.87 (m, 2H); 13C NMR (100 MHz, Chloroform-d) δ 191.3, 163.1, 140.5, 
O
Br
Et
O
Br
Me
O
Br
Ph
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128.7, 128.5, 126.6, 123.3, 41.3, 37.8, 33.2, 32.9, 22.0; IR (Neat film NaCl) 2932, 2865, 1681, 
1598, 1495, 1454, 1269, 1175, 978, 795, 749, 700 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d 
for C14H16BrO  [M+H]+: 279.0384, found 279.0370.  
  
General procedure B for the synthesis of the 2-bromo-enones 
 
A flame-dried flask under nitrogen was charged with magnesium turnings (260 mg, 20 mmol, 
2.0 equiv,), the bromo derivative (2 mmol, 0.2 equiv), dibromoethane (0.2 mmol, 0.01 equiv) 
and 5 mL of THF.  The reaction was heated to 50 ºC to initiate the Grignard reagent formation.  
Then, a solution of the bromo derivative (18 mmol, 1.8 equiv) in 15 mL of THF was added to the 
reaction and the resulting mixture was heated for 30 min.  The reaction was then cooled to room 
temperature and a solution of 2-bromo-3-ethoxycyclohex-2-en-1-one (2.20 g, 10 mmol, 1.0 
equiv) in THF (15 mL) was added slowly.  The reaction was heated at 50 ºC until no starting 
material remained by TLC.  The reaction was allowed to cool to ambient temperature, then 
quenched with 2M HCl and stirred for 2 h.  The reaction was diluted with water and extracted 
with Et2O.  The combined organic phases were dried over Na2SO4 and concentrated.  The crude 
product was purified by silica gel column chromatography to provide the desired product. 
 
 
2-bromo-3-(4-methylphenethyl)cyclohex-2-en-1-one (1f) 
Purified by column chromatography (20% AcOEt in Hexanes) provide the desired product as a 
white solid (2.248 g, 77% yield); 1H NMR (500 MHz, Chloroform-d) δ 7.11 (s, 4H), 2.87 – 2.72 
(m, 4H), 2.60 – 2.54 (m, 2H), 2.40 (t, J = 6.0 Hz, 2H), 2.34 (s, 3H), 1.99 – 1.90 (m, 2H); 13C 
NMR (100 MHz, Chloroform-d) δ 191.2, 163.2, 137.3, 136.0, 129.3, 128.3, 123.1, 41.3, 37.8, 
33.1, 32.4, 21.9, 21.1; IR (Neat film NaCl) 2925, 2866, 1681, 1596, 1514, 1454, 1425, 1269, 
1. Mg (2 equiv)
BrCH2CH2Br (0.05 equiv)
THF, 50 ºC
Br
O
OEt
2.
1 equiv
R Br
3. HCl 2 M, 25 °C, 2h
O
Br
R
O
Br
Me
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1174, 1127, 978, 808 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C15H18BrO  [M+H]+: 
293.0541, found 293.0546. 
 
 
2-bromo-3-(4-fluorophenethyl)cyclohex-2-en-1-one (1g) 
Purified by column chromatography (20% AcOEt in Hexanes) to provide the desired product as 
white solid (2.368 g, 80% yield); 1H NMR (500 MHz, Chloroform-d) δ 7.22 – 7.12 (m, 2H), 7.03 
– 6.93 (m, 2H), 2.85 (dd, J = 9.6, 6.6 Hz, 2H), 2.79 – 2.70 (m, 2H), 2.62 – 2.50 (m, 2H), 2.39 (t, 
J = 6.0 Hz, 2H), 1.98 – 1.89 (m, 2H); 13C NMR (100 MHz, Chloroform-d) δ 191.1, 162.6, 161.6 
(d, J = 244.3 Hz), 136.0 (d, J = 3.2 Hz), 129.8 (d, J = 7.8 Hz), 123.3, 115.4 (d, J = 21.2 Hz), 
41.2, 37.7, 33.1, 31.9, 21.9; 19F NMR (282 MHz, Chloroform-d) δ -116.56 (tt, J = 8.7, 5.4 Hz); 
IR (Neat Film NaCl) 2932, 2868, 1693, 1681, 1599, 1512, 1505, 1222, 979, 824, 805, 771 cm-1; 
HRMS (MM: ESI-APCI+) m/z calc’d for C14H15BrFO  [M+H]+: 297.0290, found 297.0304. 
 
 
 
2-bromo-3-(4-methoxyphenethyl)cyclohex-2-en-1-one (1h) 
Purified by column chromatography (25% AcOEt in Hexanes) to provide the desired product as 
a white solid (3.0 g, 65% yield); 1H NMR (500 MHz, Chloroform-d) δ 7.18 – 7.09 (m, 2H), 6.90 
– 6.74 (m, 2H), 3.80 (s, 3H), 2.86 – 2.80 (m, 2H), 2.75 (ddd, J = 8.6, 6.6, 1.3 Hz, 2H), 2.60 – 
2.54 (m, 2H), 2.38 (t, J = 6.0 Hz, 2H), 1.99 – 1.89 (m, 2H); 13C NMR (100 MHz, Chloroform-d) 
δ 191.23, 163.23, 158.22, 132.41, 129.32, 123.09, 113.97, 55.30, 41.42, 37.75, 33.12, 31.91, 
21.93; IR (Neat film NaCl) 2933, 2834, 1681, 1597, 1513,1454, 1426, 1246, 1176, 1034, 978, 
822, 801 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C15H18BrO2  [M+H]+: 309.0490, found 
309.0500.  
O
Br
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2-bromo-3-(4-phenylbut-3-yn-1-yl)cyclohex-2-en-1-one (1i)3 
Purified by column chromatography (20% AcOEt in Hexanes) to provide the desired product as 
a colorless oil (1.5 g, 50% yield); 1H NMR (500 MHz, Chloroform-d) δ 7.35 (qd, J = 3.8, 1.6 Hz, 
2H), 7.29 – 7.24 (m, 3H), 2.78 (dd, J = 7.5, 5.7 Hz, 2H), 2.71 (td, J = 6.8, 1.4 Hz, 2H), 2.63 (t, J 
= 6.0 Hz, 2H), 2.58 (dd, J = 7.4, 6.0 Hz, 2H), 2.06 – 1.96 (m, 2H); 13C NMR (100 MHz, 
Chloroform-d) δ 191.1, 162.0, 131.5, 128.3, 128.0, 123.7, 123.3, 87.8, 81.9, 37.8, 37.8, 33.2, 
21.9, 17.0; IR (Neat film NaCl) 2942, 2866, 1681, 1597, 1441, 1271, 1175, 978, 757, 689 cm-1; 
HRMS (MM: ESI-APCI+) m/z calc’d for C16H16BrO  [M+H]+: 303.0384, found 303.0387 
 
 
 
 
General procedure for CBS reduction of ketones 
 
 
 
To a stirred solution of (R)-α,α-Diphenylprolinol (0.2 equiv) in THF (0.1 M) was added 
trimethyl borate (0.24 equiv) and the resulting mixture was stirred for 1 h at room temperature.  
Then, borane N,N-diethylaniline complex (1.2 equiv) was added and the reaction was cooled to 0 
ºC.  After 10 min of stirring at this temperature, a solution of 1 in THF (0.5 M) was added slowly 
over 3 hours.  Following completion of the addition, the reaction was quenched with 2 M HCl 
and extracted with Et2O.  The combined organic layers were dried over Na2SO4 and 
concentrated.  The crude mixture was purified by column chromatography to provide the desired 
alcohol. 
 
O
Br
Ph
O
Br
R
(R)-ɑ,ɑ-Diphenylprolinol (0.2 equiv)
B(OMe)3 (0.24 equiv)
BH3-N,N-diethylaniline (1.2 equiv) Br
OH
R
1 2
THF, 0 ºC
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(S)-2-bromo-3,4,5,6-tetrahydro-[1,1'-biphenyl]-3-ol (2a) 
Purified by column chromatography (20% EtOAc in Hexanes) to provide the desired product as  
a white solid (250 mg, 99% yield); 99% ee, [α]D25 -61.8 (c 0.70, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.38 (tt, J = 7.6, 1.4 Hz, 2H), 7.34 – 7.29 (m, 1H), 7.26 – 7.22 (m, 2H), 4.44 
(ddt, J = 4.8, 2.8, 1.5 Hz, 1H), 2.68 (s, 1H), 2.51 – 2.33 (m, 2H), 2.08 – 1.89 (m, 3H), 1.85 – 1.73 
(m, 1H); 13C NMR (100 MHz, Chloroform-d) δ 142.3, 141.7, 128.3, 127.7, 127.5, 123.6, 71.1, 
34.5, 31.8, 18.6; IR (Neat film NaCl) 3382, 2930, 1489, 1441, 1331, 1064, 990, 756, 697 cm-1; 
HRMS (MM: ESI-APCI+) m/z calc’d for C12H14BrO [M-OH]+: 235.0117, found 235.0125; SFC 
conditions: 15% IPA, Chiralpak IC column, λ = 210 nm, tR (min): minor = 3.90, major = 4.74. 
 
 
 
 
(S)-3-allyl-2-bromocyclohex-2-en-1-ol (2b) 
Purified by column chromatography (20% EtOAc in Hexanes) to provide the desired product as 
a colorless oil (195 mg, 90% yield); 97% ee, [α]D25 -102.1 (c 0.70, CHCl3); 1H NMR (500 MHz, 
OH
Br
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Chloroform-d) δ 5.75 (ddt, J = 16.8, 10.0, 6.7 Hz, 1H), 5.18 – 5.00 (m, 2H), 4.28 (t, J = 4.6 Hz, 
1H), 2.96 (ddtd, J = 6.7, 4.7, 1.5, 0.7 Hz, 2H), 2.21 – 2.02 (m, 2H), 1.95 – 1.84 (m, 2H), 1.83 – 
1.72 (m, 1H), 1.69 – 1.53 (m, 1H); 13C NMR (100 MHz, Chloroform-d) δ 138.5, 133.6, 123.6, 
116.7, 71.1, 41.6, 32.0, 31.3, 18.3; IR (Neat film, NaCl) 3382, 2932, 1636, 1447, 1335, 1170, 
1075, 993, 971, 917, 798, 699 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C9H12Br  [M-
OH]+: 199.0117, found 199.0126; SFC conditions: 10% IPA, Chiralpak IC column, λ = 210 nm, 
tR (min): minor = 3.60, major = 4.05. 
 
 
 
 
(S)-2-bromo-3-ethylcyclohex-2-en-1-ol (2c) 
Purified by column chromatography (20% EtOAc in Hexanes) to provide the desired product as  
a white solid (203 mg, 99% yield); 97% ee, [α]D25 -90.2 (c 0.70, CHCl3); 1H NMR (400 MHz, 
Chloroform-d) δ 4.23 (t, J = 4.6 Hz, 1H), 2.42 (s, 1H), 2.22 – 2.04 (m, 4H), 1.88 – 1.82 (m, 2H), 
1.81 – 1.68 (m, 1H), 1.65 – 1.56 (m, 1H), 0.99 (t, J = 7.6 Hz, 3H); 13C NMR (100 MHz, 
Chloroform-d) δ 142.1, 122.0, 71.1, 32.1, 30.9, 30.4, 18.4, 11.4; IR (Neat film, NaCl) 3366, 
2934, 2872, 1651, 1455, 1337, 1166, 1077, 978, 914, 801, 725 cm-1; HRMS (MM: ESI-APCI+) 
OH
Br
Et
Supporting Information for Velasco-Rubio, Alexy, Yoritate, Wright and Stoltz SI21	
m/z calc’d for C8H12Br  [M-OH]+: 187.0117, found 187.0123; Chiral GC: 120 ºC Isotherm, GTA 
column, FID detector, tR (min): minor = 14.52, major = 15.77. 
 
 
 
 
(S)-2-bromo-3-methylcyclohex-2-en-1-ol (2d) 
Purified by column chromatography (20% EtOAc in Hexanes) to provide the desired product as  
a white solid (189 mg, 99% yield); 98% ee, [α]D25 -100.5 (c 0.70, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 4.27 (tq, J = 4.6, 1.3 Hz, 1H), 2.25 – 2.03 (m, 3H), 1.92 – 1.86 (m, 2H), 1.86 – 
1.83 (m, 3H), 1.83 – 1.75 (m, 1H), 1.67 – 1.60 (m, 1H); 13C NMR (100 MHz, Chloroform-d) δ 
137.1, 122.5, 71.0, 33.3, 32.0, 23.5, 18.2; IR (Neat film, NaCl) 3334, 2936, 2864, 1654, 1438, 
1337, 1166, 1078, 1010, 978, 794 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C7H10Br  [M-
OH]+: 172.9960, found 172.9965; Chiral GC: 120 ºC Isotherm, GTA column, FID detector, tR 
(min): minor = 11.10, major = 12.84. 
OH
Br
Me
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(S)-2-bromo-3-phenethylcyclohex-2-en-1-ol (2e) 
Purified by column chromatography (20% EtOAc in Hexanes) to provide the desired product as  
a white solid (278 mg, 99% yield); 97% ee, [α]D25 -50.2 (c 0.70, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.31 (t, J = 7.6 Hz, 2H), 7.23 (dd, J = 8.0, 3.1 Hz, 3H), 4.31 – 4.26 (m, 1H), 
2.80 – 2.73 (m, 2H), 2.49 (ddt, J = 13.6, 7.3, 3.4 Hz, 2H), 2.35 (s, 1H), 2.20 – 2.02 (m, 2H), 1.88 
(dd, J = 7.9, 4.5 Hz, 2H), 1.83 – 1.71 (m, 1H), 1.63 (dt, J = 13.6, 5.1 Hz, 1H); 13C NMR (100 
MHz, Chloroform-d) δ 141.4, 140.2, 128.4, 128.4, 126.1, 123.5, 71.1, 39.3, 33.3, 32.0, 31.9, 
18.3; IR (Neat film, NaCl) 3390, 2934, 2863, 1495, 1454, 1335, 1077, 972, 748, 699cm-1; HRMS 
(MM: ESI-APCI+) m/z calc’d for C14H16Br  [M-OH]+: 263.0430, found 263.0420; SFC 
conditions: 15% IPA, Chiralpak OJ-H column, λ = 210 nm, tR (min): minor = 5.03, major = 5.43. 
OH
Br
Ph
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(S)-2-bromo-3-(4-methylphenethyl)cyclohex-2-en-1-ol (2f) 
Purified by column chromatography (20% EtOAc in Hexanes) to provide the desired product as  
a white solid (292 mg, 99% yield); 94% ee, [α]D25 -59.4 (c 0.70, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.19 (s, 3H), 4.35 (t, J = 4.6 Hz, 1H), 2.86 – 2.71 (m, 2H), 2.55 (tdq, J = 11.3, 
7.8, 3.5 Hz, 3H), 2.41 (s, 3H), 2.30 – 2.07 (m, 2H), 2.01 – 1.89 (m, 2H), 1.84 (dddd, J = 14.1, 
10.4, 8.5, 5.3 Hz, 1H), 1.75 – 1.65 (m, 1H); 13C NMR (100 MHz, Chloroform-d) δ 140.3, 138.4, 
135.5, 129.1, 128.3, 123.4, 71.2, 39.5, 32.9, 32.1, 31.9, 21.1, 18.4; IR (Neat film, NaCl) 3392, 
2932, 2863, 1514, 1454, 1334, 1249, 1163, 1076, 806, 610 cm-1; HRMS (MM: ESI-APCI+) m/z 
calc’d for C15H18Br [M-OH]+: 277.0586, found 277.0574; SFC conditions: 10% IPA, Chiralpak 
OJ-H column, λ = 210 nm, tR (min): minor = 7.79, major = 8.70. 
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Br
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(S)-2-bromo-3-(4-fluorophenethyl)cyclohex-2-en-1-ol (2g) 
Purified by column chromatography (20% AcOEt in Hexanes) to provide the desired product as  
a white solid (296 mg, 99% yield); 97% ee, [α]D25 -59.9 (c 0.70, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.19 – 7.13 (m, 2H), 7.00 – 6.94 (m, 2H), 4.27 (t, J = 4.7 Hz, 1H), 2.72 (ddd, J 
= 9.0, 6.9, 2.5 Hz, 2H), 2.53 – 2.39 (m, 2H), 2.26 (s, 1H), 2.18 – 1.99 (m, 2H), 1.92 – 1.83 (m, 
2H), 1.76 (dtt, J = 16.7, 8.4, 5.4 Hz, 1H), 1.70 – 1.54 (m, 1H); 13C NMR (101 MHz, Chloroform-
d) δ 161.4 (d, J = 243.7 Hz), 139.9, 136.9 (d, J = 3.3 Hz), 129.8 (d, J = 7.8 Hz), 123.7, 115.1 (d, 
J = 21.2 Hz), 71.1, 39.3, 32.4, 31.9, 31.9, 18.3; 19F NMR (282 MHz, Chloroform-d) δ -117.34 
(tt, J = 8.9, 5.4 Hz); IR (Neat film, NaCl) 3392, 2932, 2864, 1600, 1509, 1221, 1157, 1076, 973, 
825 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C14H15BrF  [M-OH]+: 281.0336, found 
281.0327; SFC conditions: 10% IPA, Chiralpak OJ-H column, λ=210, tR (min): minor = 4.73, 
major = 5.63. 
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Br
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(S)-2-bromo-3-(4-methoxyphenethyl)cyclohex-2-en-1-ol (2h) 
Purified by column chromatography (20% AcOEt in Hexanes) to provide the desired product as  
a white solid (308 mg, 99% yield); 96% ee, [α]D25 -59.9 (c 0.70, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.19 – 7.08 (m, 2H), 6.91 – 6.67 (m, 2H), 4.27 (t, J = 4.6 Hz, 1H), 3.80 (s, 3H), 
2.75 – 2.67 (m, 2H), 2.50 – 2.40 (m, 2H), 2.35 (s, 1H), 2.19 – 2.00 (m, 2H), 1.92 – 1.84 (m, 2H), 
1.76 (dtt, J = 19.6, 8.7, 5.3 Hz, 1H), 1.68 – 1.56 (m, 1H); 13C NMR (100 MHz, Chloroform-d) δ 
158.0, 140.3, 133.5, 129.4, 123.5, 113.9, 71.2, 55.4, 39.6, 32.5, 32.1, 32.0, 18.4; IR (Neat film, 
NaCl) 3380, 2935, 2863, 1611, 1511, 1454, 1243, 1174, 1033, 972, 818, 728 cm-1; HRMS (MM: 
ESI-APCI+) m/z calc’d for C15H18BrO  [M-OH]+: 293.0535, found 293.0527; SFC conditions: 20 
% IPA, Chiralpak OJ-H column, λ = 210 nm, tR (min): minor = 4.72, major = 5.45. 
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(S)-2-bromo-3-(4-phenylbut-3-yn-1-yl)cyclohex-2-en-1-ol (2i) 
Purified by column chromatography (20% Et2O in Hexanes) to provide the desired product as  a 
brown oil (213 mg, 70% yield); 91% ee, [α]D25 -62.8 (c 0.70, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.42 – 7.36 (m, 2H), 7.31 – 7.26 (m, 3H), 4.29 (t, J = 4.7 Hz, 1H), 2.59 (ddd, J 
= 7.1, 6.3, 3.1 Hz, 2H), 2.52 (dd, J = 8.7, 7.0 Hz, 2H), 2.30 (dtd, J = 17.2, 5.1, 1.2 Hz, 2H), 2.25 
– 2.19 (m, 1H), 1.91 (dt, J = 9.5, 4.6 Hz, 2H), 1.87 – 1.76 (m, 1H), 1.71 – 1.61 (m, 1H); 13C 
NMR (100 MHz, Chloroform-d) δ 139.3, 131.5, 128.3, 127.7, 124.2, 123.7, 89.0, 81.2, 71.1, 
36.2, 32.0, 32.0, 18.3, 17.3; IR (Neat film, NaCl) 3432, 2933, 2864, 2364, 1681, 1597, 1489, 
1442, 1335, 1272, 1175, 1076, 977, 757, 692 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
C16H16Br  [M-OH]+: 287.0430, found 287.0437; SFC conditions: 20% IPA, Chiralpak AD-H 
column, λ = 210 nm, tR (min): minor = 6.35, major = 7.31. 
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Product Derivatization 
 
 
(S)-N-(1-allyl-2-bromocyclohex-2-en-1-yl)-4-methoxyaniline (4)4 
To a stirred solution of 3b (209 mg, 0.5 mmol) in 10:1 iPrOH/H2O (2.5 mL) was added NaBH4 
(115 mg, 3 mmol) and the resulting mixture stirred for 16 h at 25 °C.  The crude reaction was 
diluted with H2O and extracted with CH2Cl2.  The combined organic layers were washed with 
brine and dried with MgSO4 and concentrated.  The crude product was purified by silica gel 
column chromatography (2:1 CH2Cl2/hexanes) to afford the desired product as a brown oil (120 
mg, 75% yield). [α]D25 -18.1 (c 0.70, CHCl3); 1H NMR (400 MHz, Chloroform-d) δ 6.81 – 6.72 
(m, 4H), 6.31 (dd, J = 4.9, 3.5 Hz, 1H), 5.88 (dddd, J = 16.5, 10.2, 8.7, 6.1 Hz, 1H), 5.29 – 5.18 
(m, 2H), 3.75 (s, 3H), 3.57 (d, J = 7.5 Hz, 1H), 2.61 – 2.42 (m, 2H), 2.26 – 1.99 (m, 3H), 1.89 – 
1.51 (m, 3H); 13C NMR (100 MHz, Chloroform-d) δ 153.5, 138.9, 133.3, 132.9, 119.8, 119.7, 
114.4, 59.5, 55.6, 44.5, 30.8, 27.6, 19.7; IR (Neat film, NaCl) 3493, 2621, 1636, 1512, 1258, 
937, 738 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C16H21BrNO  [M+H]+ 322.0801, found 
322.0794. 
 
 
 
 
Br
N
O
CF3
OMe
NaBH4 (6 equiv) Br
NH
OMe
CAN (2.5 equiv) Br
NH2•HCliPrOH/H2O (10:1)
25 °C, 16 h
75% yield
MeCN/H2O (1:1)
0 ºC to 25 °C, 2 h
80% yield
Br
NH
OMe
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(S)-1-allyl-2-bromocyclohex-2-en-1-aminium Chloride (5)4 
A solution of PMP-protected amine 4 (65 mg, 0.2 mmol) in 6.0 mL MeCN was cooled in an ice-
bath and treated with a solution of CAN (275 mg, 0.5 mmol, 2.5 equiv) in water (6 mL) 
dropwise.  The reaction allowed to warm to 25 °C and stirred for 3 h.  The crude reaction was 
diluted with water, washed with Et2O, and the organic layer discarded.  The aqueous layer was 
basified to pH 10 with a saturated Na2CO3 solution and extracted with Et2O.  The combined 
organic layers were dried with MgSO4 and treated with a 1 M HCl solution in Et2O, and 
concentrated to afford the hydrochloride salt of the product as a white solid (40 mg, 80% yield). 
[α]D25 51.0 (c 0.70, CHCl3);  1H NMR (500 MHz, Methanol-d4) δ 6.51 (t, J = 4.1 Hz, 1H), 5.73 
(dddd, J = 16.6, 10.1, 8.1, 6.3 Hz, 1H), 5.33 – 5.20 (m, 2H), 2.69 (dd, J = 14.0, 6.3 Hz, 1H), 2.56 
(dd, J = 14.0, 8.1 Hz, 1H), 2.26 – 2.04 (m, 3H), 2.04 – 1.91 (m, 2H), 1.84 – 1.67 (m, 2H); 13C 
NMR (100 MHz, Methanol-d4) δ 138.3, 129.9, 121.3, 120.7, 58.2, 41.6, 32.2, 27.2, 17.2; IR 
(Neat film, NaCl) 2933, 2863, 1603 1515, 1447, 361, 984, 925, 761, 681 cm-1; HRMS (MM:ESI-
APCI+) m/z calc’d for C9H15BrN  [M-Cl]+ , 216.0382, found 216.0372. 
 
 
 
(S)-2,2,2-trifluoro-N-(4-methoxyphenyl)-N-(2-oxo-1-phenethylcyclohexyl)acetamide (6)5  
A vial was charged with Co(acac)2 (90 mg, 0.35 mmol, 1.00 equiv) and the vial was evacuated 
and backfilled with oxygen three times.  Isopropanol was then added (2 mL) followed by starting 
material 3e (170 mg, 0.35 mmol, 1.00 equiv) and Et3SiH (280 µL, 1.75 mmol, 5 equiv).  The 
resulting mixture was heated to 50 °C for 2 h under a balloon of oxygen.  The crude reaction 
mixture was directly concentrated and purified by silica gel column chromatography (20% 
EtOAc/hexanes) to provide the desired product as a colorless oil (110 mg, 75% yield). [α]D25 
72.1 (c 1.0, CHCl3);	1H NMR (400 MHz, Chloroform-d) δ 7.50 – 7.43 (m, 1H), 7.30 – 7.09 (m, 
4H), 6.95 (ddd, J = 13.1, 8.7, 2.9 Hz, 2H), 6.81 (dt, J = 6.3, 1.4 Hz, 2H), 3.86 (s, 3H), 2.73 (dtd, 
Br
NH2•HCl
Br
N
PMP
COCF3
Co(acac)2 (1 equiv)
Et3SiH (5 equiv), O2 (1 atm)
iPrOH, 50 ºC, 2 h
75%
O
N
PMP
COCF3
Ph Ph
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J = 15.9, 4.5, 1.8 Hz, 1H), 2.51 – 2.34 (m, 2H), 2.33 – 1.85 (m, 8H), 1.85 – 1.58 (m, 3H); 13C 
NMR (100 MHz, Chloroform-d) δ 205.0, 160.4, 157.3 (q, J = 35.1 Hz), 140.9, 132.4, 131.8, 
128.5, 128.1, 127.7, 126.2, 122.3, 116.3 (q, J = 288.3 Hz), 114.0, 113.9, 72.0, 55.6, 40.1, 36.5, 
36.1, 30.4, 25.1, 22.6; IR (Neat film, NaCl) 2945, 1720, 1962, 1510, 1300, 1252, 1185, 1203, 
1155, 1032, 737, 703 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for C23H25F3NO3 [M+H]+: 
420.1786, found 420.1796. 
 
 
2,2,2-trifluoro-N-((1S,3S)-3-hydroxy-2-oxo-1-phenethylcyclohexyl)-N-(4-
methoxyphenyl)acetamide (7) 
To a solution of 3e (96 mg, 0.2 mmol, 1 equiv) in wet CH2Cl2 (0.1 M) was added pyridine (40 
µL, 0.5 mmol, 2.5 equiv).  This solution was then cooled to –78 ºC and O3 was bubbled through 
until no starting material remained by TLC (~ 1 h).  O2 was then bubbled through the solution for 
10 min and the reaction was allowed to warm up to 25 °C.  After 3 h at 25 °C, the product was 
purified by column chromatography (20% to 50% EtOAc/hexanes) to provide the desired 
product as a white foam (75 mg, 85% yield). [α]D25 88.3 (c 1, CHCl3); 1H NMR (400 MHz, 
Chloroform-d) δ 7.44 (d, J = 8.6 Hz, 1H), 7.18 (dt, J = 14.1, 7.8 Hz, 4H), 7.02 – 6.89 (m, 2H), 
6.87 – 6.67 (m, 2H), 4.23 (dd, J = 11.9, 6.3 Hz, 1H), 3.86 (s, 3H), 3.60 (s, 1H), 2.50 – 2.29 (m, 
3H), 2.16 (d, J = 34.0 Hz, 2H), 2.04 (d, J = 12.2 Hz, 1H), 2.00 – 1.73 (m, 4H);	13C NMR (100 
MHz, Chloroform-d) δ 205.4, 160.5, 157.2 (q, J = 35.1 Hz), 140.2, 132.5, 132.1, 128.5, 128.0, 
126.3, 116.2 (q, J = 288.5 Hz), 114.1, 113.9, 74.2, 72.5, 55.5, 36.4, 35.3, 30.2, 19.7;	19F NMR 
(282 MHz, Chloroform-d) δ –67.4; IR (Neat film, NaCl) 3469, 2939, 1723, 1693, 1509, 1455, 
1251, 1201, 1184, 1154, 1030, 759, 701 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
C23H25F3NO4 [M+H]+: 436.1735, found 436.1733. 
 
 
 
O3, pyridine (2.5 equiv)
CH2Cl2, –78 ºC to 25 °C, 4 h
85%
Br
N
PMP
COCF3
Ph
N
PMP
COCF3
Ph
O
HO
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(2S,6S)-6-hydroxy-2-((4-methoxyphenyl)amino)-2-phenethylcyclohexan-1-one (8) 
A solution of 3e (96 mg, 0.2 mmol, 1.00 equiv) in wet MeOH (0.1 M) was cooled to –78 ºC and 
O3 was bubbled through until no starting material remained by TLC (~30 min).  O2 was then 
bubbled through for 10 min and DMS (55 µL, 0.6 mmol, 3 equiv) was added. The reaction was 
allowed to warm up to 25 °C and stirred overnight.  The reaction was washed with a saturated 
solution of NH4Cl and extracted with CH2Cl2.  The crude product was purified by column 
chromatography (20% to 50% EtOAc/hexanes) to provide the desired product as an amorphous 
brown solid (55 mg, 80% yield). [α]D25 50.2 (c 1, CHCl3); 1H NMR (500 MHz, Chloroform-d) δ 
7.25 – 7.21 (m, 2H), 7.19 – 7.14 (m, 1H), 6.98 – 6.93 (m, 2H), 6.82 – 6.74 (m, 4H), 4.47 (dd, J = 
12.3, 6.8 Hz, 1H), 3.78 (s, 3H), 2.73 – 2.62 (m, 1H), 2.57 – 2.44 (m, 2H), 2.32 (ddd, J = 14.2, 
12.2, 4.6 Hz, 1H), 2.25 – 2.08 (m, 2H), 1.89 – 1.77 (m, 3H), 1.55 (dddd, J = 12.6, 10.6, 8.7, 5.5 
Hz, 1H); 13C NMR (100 MHz, Chloroform-d) δ 212.1, 153.5, 141.0, 138.1, 128.5, 128.3, 126.2, 
120.1, 114.6, 72.9, 66.9, 55.7, 40.9, 37.1, 37.0, 29.5, 19.2; IR (Neat film, NaCl) 3374, 2948, 
1711, 1510, 1454, 1237, 1035, 826, 700 cm-1; HRMS (MM: ESI-APCI+) m/z calc’d for 
C21H26NO3  [M+H]+: 340.1912, found 340.1923. 
 
 
N-((1S,3S)-3-bromo-2-oxo-1-phenethylcyclohexyl)-2,2,2-trifluoro-N-(4-
methoxyphenyl)acetamide (9) 
To a solution of 3e (96 mg, 0.2 mmol, 1.00 equiv) in H2O (0.55 mL), acetonitrile (1.25 mL), and 
EtOAc (1.25 mL) was added sodium periodate (NaIO4, 274 mg, 1.28 mmol, 6.40 equiv) and 
ruthenium(III) trichloride (RuCl3, 4 µL, 0.1 M solution in H2O, 0.02 equiv).  The reaction 
mixture was then stirred at room temperature for 18 h, at which time consumption of starting 
material was complete as determined by TLC analysis.  The crude reaction mixture was washed 
with a saturated solution of NaHCO3, and the aqueous layer extracted with EtOAc.  The 
combined organic layers were dried over anhydrous Na2SO4 and concentrated.  The crude 
MeOH, –78 °C; 
DMS –78 °C to 25 °C
80%
Br
N
PMP
COCF3 O3 NH
PMPO
HO
PhPh
2 mol% RuCl3
NaIO4 (6.5 equiv)
Br
N
PMP
COCF3
Ph
N
PMP
COCF3
Ph
O
Br
MeCN/EtOAc/H2O
25 °C, 16 h
60%
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product was purified by column chromatography (20% EtOAc/hexanes) to provide the desired 
product as a white foam (60 mg, 60% yield). [α]D25 50.2 (c 1.0, CHCl3); 1H NMR (500 MHz, 
Chloroform-d) δ 7.55 (ddd, J = 8.7, 2.7, 1.1 Hz, 1H), 7.23 – 7.10 (m, 4H), 6.99 (ddd, J = 21.4, 
8.7, 3.0 Hz, 2H), 6.85 – 6.74 (m, 2H), 4.80 (d, J = 1.3 Hz, 1H), 3.89 (s, 3H), 2.69 (ddq, J = 14.5, 
10.7, 3.5 Hz, 1H), 2.49 – 2.36 (m, 2H), 2.31 – 2.16 (m, 3H), 2.02 (dtt, J = 13.9, 8.3, 2.8 Hz, 2H), 
1.85 (s, 1H), 1.80 (ddd, J = 15.3, 10.8, 5.9 Hz, 1H); 13C NMR (100 MHz, Chloroform-d) δ 196.6, 
160.6, 157.6 (q, J = 35.8 Hz), 141.0, 132.4, 131.4, 128.4, 128.2, 126.8, 126.1, 116.1 (q, J = 287.9 
Hz), 114.3, 113.9, 71.3, 55.7, 51.3, 38.7, 37.2, 34.3, 30.5, 18.9; 19F NMR (282 MHz, 
Chloroform-d) δ –67.5; IR (Neat film, NaCl) 3493, 2942, 1716, 1682, 1509, 1455, 1254, 1206, 
1184, 1165, 1031, 752 cm-1; HRMS (MM:ESI-APCI+) m/z calc’d for C23H24BrF3NO3  [M+H]+: 
498.0891, found 498.0891. 
 
X-Ray Crystal Structure for 8 (V19265) 
An X-ray crystal structure of compound 8 (V19265) was grown by vapor diffusion. 
Figure S1. X-Ray Coordinate of compound 8 (V19265) 
 
  Table 1.  Crystal data and structure refinement for V19265. 
Empirical formula  C21 H25 N O3 
Formula weight  339.42 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Supporting Information for Velasco-Rubio, Alexy, Yoritate, Wright and Stoltz SI32	
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 5.9218(7) Å a= 90°. 
 b = 7.5604(10) Å b= 90°. 
 c = 41.115(6) Å g = 90°. 
Volume 1840.8(4) Å3 
Z 4 
Density (calculated) 1.225 Mg/m3 
Absorption coefficient 0.650 mm-1 
F(000) 728 
Crystal size 0.300 x 0.100 x 0.100 mm3 
Theta range for data collection 4.301 to 79.710°. 
Index ranges -5<=h<=7, -8<=k<=9, -51<=l<=50 
Reflections collected 19853 
Independent reflections 3921 [R(int) = 0.0518] 
Completeness to theta = 67.679° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7451 and 0.6491 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3921 / 2 / 233 
Goodness-of-fit on F2 1.032 
Final R indices [I>2sigma(I)] R1 = 0.0307, wR2 = 0.0714 
R indices (all data) R1 = 0.0340, wR2 = 0.0731 
Absolute structure parameter -0.02(8) 
Extinction coefficient n/a 
Largest diff. peak and hole                        0.184 and -0.169 e.Å-3 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for V19265.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
 x y z U(eq) 
______________________________________________________________________________
__   
N(1) 2984(2) 4882(2) 3921(1) 16(1) 
C(1) 4851(2) 5030(2) 4154(1) 14(1) 
C(2) 3912(3) 5870(2) 4466(1) 15(1) 
O(1) 1984(2) 6407(2) 4486(1) 20(1) 
C(3) 5573(3) 5965(2) 4746(1) 19(1) 
O(2) 4536(2) 6809(2) 5013(1) 24(1) 
C(4) 6395(3) 4103(2) 4829(1) 23(1) 
C(5) 7396(3) 3169(2) 4532(1) 21(1) 
C(6) 5718(3) 3171(2) 4249(1) 18(1) 
C(7) 3311(2) 4934(2) 3581(1) 15(1) 
C(8) 5057(3) 4034(2) 3423(1) 17(1) 
C(9) 5305(3) 4126(2) 3086(1) 18(1) 
C(10) 3762(3) 5069(2) 2900(1) 19(1) 
O(3) 3866(2) 5233(2) 2566(1) 26(1) 
C(13) 5968(3) 4833(3) 2416(1) 29(1) 
C(11) 1965(3) 5913(2) 3053(1) 20(1) 
C(12) 1766(3) 5864(2) 3389(1) 18(1) 
C(14) 6760(2) 6244(2) 4026(1) 15(1) 
C(15) 5972(3) 8156(2) 3974(1) 19(1) 
C(16) 7559(3) 9143(2) 3752(1) 17(1) 
C(17) 7148(3) 9212(2) 3419(1) 20(1) 
C(18) 8634(3) 10088(2) 3211(1) 22(1) 
C(19) 10541(3) 10910(2) 3336(1) 22(1) 
C(20) 10992(3) 10823(2) 3668(1) 22(1) 
C(21) 9512(3) 9938(2) 3874(1) 19(1) 
______________________________________________________________________________  
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 Table 3.   Bond lengths [Å] and angles [°] for  V19265. 
_____________________________________________________  
N(1)-C(7)  1.4128(18) 
N(1)-C(1)  1.4668(19) 
N(1)-H(1N)  0.894(18) 
C(1)-C(2)  1.534(2) 
C(1)-C(6)  1.546(2) 
C(1)-C(14)  1.548(2) 
C(2)-O(1)  1.214(2) 
C(2)-C(3)  1.518(2) 
C(3)-O(2)  1.4111(19) 
C(3)-C(4)  1.528(2) 
C(3)-H(3)  1.0000 
O(2)-H(2O)  0.87(2) 
C(4)-C(5)  1.529(2) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(6)  1.532(2) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 
C(7)-C(8)  1.398(2) 
C(7)-C(12)  1.399(2) 
C(8)-C(9)  1.396(2) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.388(2) 
C(9)-H(9)  0.9500 
C(10)-O(3)  1.3786(18) 
C(10)-C(11)  1.392(2) 
O(3)-C(13)  1.421(2) 
C(13)-H(13A)  0.9800 
C(13)-H(13B)  0.9800 
C(13)-H(13C)  0.9800 
C(11)-C(12)  1.387(2) 
C(11)-H(11)  0.9500 
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C(12)-H(12)  0.9500 
C(14)-C(15)  1.535(2) 
C(14)-H(14A)  0.9900 
C(14)-H(14B)  0.9900 
C(15)-C(16)  1.507(2) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(16)-C(17)  1.395(2) 
C(16)-C(21)  1.396(2) 
C(17)-C(18)  1.394(2) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.388(3) 
C(18)-H(18)  0.9500 
C(19)-C(20)  1.389(2) 
C(19)-H(19)  0.9500 
C(20)-C(21)  1.392(2) 
C(20)-H(20)  0.9500 
C(21)-H(21)  0.9500 
 
C(7)-N(1)-C(1) 122.78(12) 
C(7)-N(1)-H(1N) 110.0(13) 
C(1)-N(1)-H(1N) 111.4(14) 
N(1)-C(1)-C(2) 107.64(12) 
N(1)-C(1)-C(6) 110.24(12) 
C(2)-C(1)-C(6) 106.67(12) 
N(1)-C(1)-C(14) 111.97(12) 
C(2)-C(1)-C(14) 107.59(12) 
C(6)-C(1)-C(14) 112.43(12) 
O(1)-C(2)-C(3) 122.75(14) 
O(1)-C(2)-C(1) 122.50(13) 
C(3)-C(2)-C(1) 114.75(13) 
O(2)-C(3)-C(2) 109.31(13) 
O(2)-C(3)-C(4) 112.41(13) 
C(2)-C(3)-C(4) 109.45(13) 
O(2)-C(3)-H(3) 108.5 
C(2)-C(3)-H(3) 108.5 
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C(4)-C(3)-H(3) 108.5 
C(3)-O(2)-H(2O) 107.7(17) 
C(3)-C(4)-C(5) 111.77(13) 
C(3)-C(4)-H(4A) 109.3 
C(5)-C(4)-H(4A) 109.3 
C(3)-C(4)-H(4B) 109.3 
C(5)-C(4)-H(4B) 109.3 
H(4A)-C(4)-H(4B) 107.9 
C(4)-C(5)-C(6) 110.78(13) 
C(4)-C(5)-H(5A) 109.5 
C(6)-C(5)-H(5A) 109.5 
C(4)-C(5)-H(5B) 109.5 
C(6)-C(5)-H(5B) 109.5 
H(5A)-C(5)-H(5B) 108.1 
C(5)-C(6)-C(1) 114.11(13) 
C(5)-C(6)-H(6A) 108.7 
C(1)-C(6)-H(6A) 108.7 
C(5)-C(6)-H(6B) 108.7 
C(1)-C(6)-H(6B) 108.7 
H(6A)-C(6)-H(6B) 107.6 
C(8)-C(7)-C(12) 117.76(13) 
C(8)-C(7)-N(1) 123.25(14) 
C(12)-C(7)-N(1) 118.93(13) 
C(9)-C(8)-C(7) 121.04(14) 
C(9)-C(8)-H(8) 119.5 
C(7)-C(8)-H(8) 119.5 
C(10)-C(9)-C(8) 120.19(14) 
C(10)-C(9)-H(9) 119.9 
C(8)-C(9)-H(9) 119.9 
O(3)-C(10)-C(9) 124.37(15) 
O(3)-C(10)-C(11) 116.30(14) 
C(9)-C(10)-C(11) 119.34(14) 
C(10)-O(3)-C(13) 116.80(13) 
O(3)-C(13)-H(13A) 109.5 
O(3)-C(13)-H(13B) 109.5 
H(13A)-C(13)-H(13B) 109.5 
Supporting Information for Velasco-Rubio, Alexy, Yoritate, Wright and Stoltz SI37	
O(3)-C(13)-H(13C) 109.5 
H(13A)-C(13)-H(13C) 109.5 
H(13B)-C(13)-H(13C) 109.5 
C(12)-C(11)-C(10) 120.21(15) 
C(12)-C(11)-H(11) 119.9 
C(10)-C(11)-H(11) 119.9 
C(11)-C(12)-C(7) 121.38(14) 
C(11)-C(12)-H(12) 119.3 
C(7)-C(12)-H(12) 119.3 
C(15)-C(14)-C(1) 112.59(12) 
C(15)-C(14)-H(14A) 109.1 
C(1)-C(14)-H(14A) 109.1 
C(15)-C(14)-H(14B) 109.1 
C(1)-C(14)-H(14B) 109.1 
H(14A)-C(14)-H(14B) 107.8 
C(16)-C(15)-C(14) 111.21(12) 
C(16)-C(15)-H(15A) 109.4 
C(14)-C(15)-H(15A) 109.4 
C(16)-C(15)-H(15B) 109.4 
C(14)-C(15)-H(15B) 109.4 
H(15A)-C(15)-H(15B) 108.0 
C(17)-C(16)-C(21) 118.79(14) 
C(17)-C(16)-C(15) 120.31(14) 
C(21)-C(16)-C(15) 120.85(14) 
C(18)-C(17)-C(16) 120.69(15) 
C(18)-C(17)-H(17) 119.7 
C(16)-C(17)-H(17) 119.7 
C(19)-C(18)-C(17) 119.91(15) 
C(19)-C(18)-H(18) 120.0 
C(17)-C(18)-H(18) 120.0 
C(18)-C(19)-C(20) 119.96(15) 
C(18)-C(19)-H(19) 120.0 
C(20)-C(19)-H(19) 120.0 
C(19)-C(20)-C(21) 120.02(15) 
C(19)-C(20)-H(20) 120.0 
C(21)-C(20)-H(20) 120.0 
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C(20)-C(21)-C(16) 120.60(14) 
C(20)-C(21)-H(21) 119.7 
C(16)-C(21)-H(21) 119.7 
_____________________________________________________________  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supporting Information for Velasco-Rubio, Alexy, Yoritate, Wright and Stoltz SI39	
Table 4.   Anisotropic displacement parameters  (Å2x 103) for V19265.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
N(1) 13(1)  20(1) 14(1)  -2(1) 1(1)  -1(1) 
C(1) 13(1)  15(1) 14(1)  -1(1) 0(1)  -1(1) 
C(2) 15(1)  15(1) 16(1)  0(1) 2(1)  -4(1) 
O(1) 14(1)  28(1) 17(1)  -5(1) 1(1)  1(1) 
C(3) 16(1)  25(1) 15(1)  -6(1) 1(1)  1(1) 
O(2) 18(1)  36(1) 18(1)  -14(1) -1(1)  0(1) 
C(4) 27(1)  28(1) 15(1)  -1(1) -2(1)  4(1) 
C(5) 24(1)  21(1) 18(1)  1(1) -3(1)  4(1) 
C(6) 22(1)  16(1) 16(1)  -1(1) 0(1)  1(1) 
C(7) 17(1)  15(1) 14(1)  -1(1) 1(1)  -2(1) 
C(8) 17(1)  16(1) 18(1)  0(1) 0(1)  1(1) 
C(9) 20(1)  16(1) 18(1)  -3(1) 3(1)  1(1) 
C(10) 22(1)  22(1) 13(1)  -1(1) 1(1)  -3(1) 
O(3) 28(1)  37(1) 13(1)  0(1) 2(1)  4(1) 
C(13) 32(1)  38(1) 16(1)  0(1) 7(1)  2(1) 
C(11) 20(1)  23(1) 18(1)  2(1) -1(1)  2(1) 
C(12) 14(1)  20(1) 18(1)  -2(1) 2(1)  1(1) 
C(14) 12(1)  15(1) 16(1)  0(1) 1(1)  -2(1) 
C(15) 16(1)  16(1) 25(1)  0(1) 4(1)  0(1) 
C(16) 18(1)  12(1) 22(1)  0(1) 4(1)  2(1) 
C(17) 18(1)  18(1) 25(1)  0(1) -2(1)  0(1) 
C(18) 26(1)  20(1) 20(1)  2(1) -1(1)  3(1) 
C(19) 24(1)  16(1) 27(1)  2(1) 7(1)  0(1) 
C(20) 21(1)  17(1) 28(1)  -3(1) 1(1)  -4(1) 
C(21) 21(1)  16(1) 19(1)  -2(1) 1(1)  -1(1) 
______________________________________________________________________________   
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Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for V19265. 
______________________________________________________________________________ 
 x  y  z  U(eq) 
______________________________________________________________________________ 
  
H(1N) 1830(30) 5580(30) 3977(5) 24 
H(3) 6901 6689 4676 22 
H(2O) 5590(40) 7310(30) 5127(6) 36 
H(4A) 5114 3399 4914 28 
H(4B) 7554 4176 5002 28 
H(5A) 7782 1934 4590 25 
H(5B) 8802 3777 4466 25 
H(6A) 4409 2423 4308 21 
H(6B) 6454 2630 4057 21 
H(8) 6091 3350 3547 20 
H(9) 6533 3541 2983 22 
H(13A) 7164 5541 2517 43 
H(13B) 5885 5108 2184 43 
H(13C) 6305 3573 2445 43 
H(11) 870 6524 2927 24 
H(12) 555 6475 3491 21 
H(14A) 8024 6237 4184 18 
H(14B) 7333 5765 3818 18 
H(15A) 4439 8152 3878 23 
H(15B) 5891 8770 4186 23 
H(17) 5840 8657 3332 24 
H(18) 8343 10122 2984 27 
H(19) 11536 11532 3196 27 
H(20) 12310 11368 3753 26 
H(21) 9834 9875 4100 22 
______________________________________________________________________________
__   
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Table 6.  Torsion angles [°] for V19265. 
________________________________________________________________  
C(7)-N(1)-C(1)-C(2) 150.99(14) 
C(7)-N(1)-C(1)-C(6) -93.03(17) 
C(7)-N(1)-C(1)-C(14) 32.94(19) 
N(1)-C(1)-C(2)-O(1) -5.1(2) 
C(6)-C(1)-C(2)-O(1) -123.39(16) 
C(14)-C(1)-C(2)-O(1) 115.76(16) 
N(1)-C(1)-C(2)-C(3) 174.48(13) 
C(6)-C(1)-C(2)-C(3) 56.17(16) 
C(14)-C(1)-C(2)-C(3) -64.68(16) 
O(1)-C(2)-C(3)-O(2) -2.2(2) 
C(1)-C(2)-C(3)-O(2) 178.20(13) 
O(1)-C(2)-C(3)-C(4) 121.28(17) 
C(1)-C(2)-C(3)-C(4) -58.28(17) 
O(2)-C(3)-C(4)-C(5) 176.86(14) 
C(2)-C(3)-C(4)-C(5) 55.20(17) 
C(3)-C(4)-C(5)-C(6) -54.08(18) 
C(4)-C(5)-C(6)-C(1) 54.73(18) 
N(1)-C(1)-C(6)-C(5) -170.37(12) 
C(2)-C(1)-C(6)-C(5) -53.78(16) 
C(14)-C(1)-C(6)-C(5) 63.92(16) 
C(1)-N(1)-C(7)-C(8) 43.0(2) 
C(1)-N(1)-C(7)-C(12) -139.76(15) 
C(12)-C(7)-C(8)-C(9) 2.7(2) 
N(1)-C(7)-C(8)-C(9) 179.92(14) 
C(7)-C(8)-C(9)-C(10) -2.3(2) 
C(8)-C(9)-C(10)-O(3) -179.95(15) 
C(8)-C(9)-C(10)-C(11) -0.3(2) 
C(9)-C(10)-O(3)-C(13) -17.7(2) 
C(11)-C(10)-O(3)-C(13) 162.65(16) 
O(3)-C(10)-C(11)-C(12) -178.00(15) 
C(9)-C(10)-C(11)-C(12) 2.3(3) 
C(10)-C(11)-C(12)-C(7) -1.9(3) 
C(8)-C(7)-C(12)-C(11) -0.7(2) 
N(1)-C(7)-C(12)-C(11) -178.00(15) 
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N(1)-C(1)-C(14)-C(15) 62.65(16) 
C(2)-C(1)-C(14)-C(15) -55.43(16) 
C(6)-C(1)-C(14)-C(15) -172.59(12) 
C(1)-C(14)-C(15)-C(16) -161.29(12) 
C(14)-C(15)-C(16)-C(17) 93.17(17) 
C(14)-C(15)-C(16)-C(21) -84.11(18) 
C(21)-C(16)-C(17)-C(18) -1.2(2) 
C(15)-C(16)-C(17)-C(18) -178.53(15) 
C(16)-C(17)-C(18)-C(19) -0.4(2) 
C(17)-C(18)-C(19)-C(20) 1.5(3) 
C(18)-C(19)-C(20)-C(21) -1.1(3) 
C(19)-C(20)-C(21)-C(16) -0.5(2) 
C(17)-C(16)-C(21)-C(20) 1.6(2) 
C(15)-C(16)-C(21)-C(20) 178.93(15) 
________________________________________________________________ 
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Table 7.  Hydrogen bonds for V19265  [Å and °]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 N(1)-H(1N)...O(1) 0.894(18) 2.19(2) 2.6591(16) 112.5(16) 
 C(3)-H(3)...O(2)#1 1.00 2.31 3.053(2) 129.9 
 O(2)-H(2O)...O(1)#1 0.87(2) 2.04(2) 2.8566(16) 157(2) 
 O(2)-H(2O)...O(2)#1 0.87(2) 2.50(2) 3.1420(10) 132(2) 
 C(13)-H(13C)...O(3)#2 0.98 2.53 3.480(3) 163.8 
 C(14)-H(14A)...O(1)#3 0.99 2.66 3.6265(19) 166.6 
____________________________________________________________________________ 
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 13C NMR (100 MHz, CDCl3) of compound 3a. 
 
Infrared spectrum (Thin Film, NaCl) of compound 3a. 
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 19F NMR (282 MHz, CDCl3) of compound 3a. 
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Infrared spectrum (Thin Film, NaCl) of compound 3b. 
 
 13C NMR (100 MHz, CDCl3) of compound 3b. 
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 19F NMR (282 MHz, CDCl3) of compound 3b. 
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 13C NMR (100 MHz, CDCl3) of compound 3c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 3c. 
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 19F NMR (282 MHz, CDCl3) of compound 3c. 
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 13C NMR (100 MHz, CDCl3) of compound 3d. 
 
Infrared spectrum (Thin Film, NaCl) of compound 3d. 
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 19F NMR (282 MHz, CDCl3) of compound 3d. 
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 13C NMR (100 MHz, CDCl3) of compound 3e. 
 
Infrared spectrum (Thin Film, NaCl) of compound 3e. 
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 19F NMR (282 MHz, CDCl3) of compound 3e. 
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 13C NMR (100 MHz, CDCl3) of compound 3f. 
 
Infrared spectrum (Thin Film, NaCl) of compound 3f. 
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 19F NMR (282 MHz, CDCl3) of compound 3f. 
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Infrared spectrum (Thin Film, NaCl) of compound 3g. 
 
 13C NMR (100 MHz, CDCl3) of compound 3g. 
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 19F NMR (282 MHz, CDCl3) of compound 3g. 
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 13C NMR (100 MHz, CDCl3) of compound 3h. 
 
Infrared spectrum (Thin Film, NaCl) of compound 3h. 
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 19F NMR (282 MHz, CDCl3) of compound 3h. 
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 13C NMR (100 MHz, CDCl3) of compound 3i. 
 
Infrared spectrum (Thin Film, NaCl) of compound 3i. 
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 13C NMR (100 MHz, CDCl3) of compound 1a. 
 
Infrared spectrum (Thin Film, NaCl) of compound 1a. 
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 13C NMR (100 MHz, CDCl3) of compound 1b. 
 
Infrared spectrum (Thin Film, NaCl) of compound 1b. 
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 13C NMR (100 MHz, CDCl3) of compound 1c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 1c. 
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 13C NMR (100 MHz, CDCl3) of compound 1d. 
 
Infrared spectrum (Thin Film, NaCl) of compound 1d. 
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 13C NMR (100 MHz, CDCl3) of compound 1e. 
 
Infrared spectrum (Thin Film, NaCl) of compound 1e. 
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 13C NMR (100 MHz, CDCl3) of compound 1f. 
 
Infrared spectrum (Thin Film, NaCl) of compound 1f. 
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 13C NMR (100 MHz, CDCl3) of compound 1g. 
 
Infrared spectrum (Thin Film, NaCl) of compound 1g. 
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 19F NMR (282 MHz, CDCl3) of compound 1g. 
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 13C NMR (100 MHz, CDCl3) of compound 1h. 
 
Infrared spectrum (Thin Film, NaCl) of compound 1h. 
 
Supporting Information for Velasco-Rubio, Alexy, Yoritate, Wright and Stoltz SI88 
 
  
 1 H
 N
M
R
 (5
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
1i
. 
 
 
Br
O
1i
Ph
Supporting Information for Velasco-Rubio, Alexy, Yoritate, Wright and Stoltz SI89 
020406080100120140160180200
ppm
16
.9
80
0
19
.5
49
0
21
.9
44
3
22
.0
33
6
25
.9
19
5
32
.5
88
2
33
.1
90
1
37
.8
00
4
37
.8
14
3
38
.4
65
0
76
.8
68
0 
CD
Cl
3
77
.1
86
0 
CD
Cl
3
77
.3
87
9
77
.5
05
0 
CD
Cl
3
81
.9
15
4
87
.8
30
5
12
3.
31
08
12
3.
67
20
12
7.
80
24
12
7.
98
15
12
8.
34
12
13
1.
49
83
16
1.
97
76
16
3.
19
89
19
1.
14
29
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 13C NMR (100 MHz, CDCl3) of compound 1i. 
 
Infrared spectrum (Thin Film, NaCl) of compound 1i. 
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 13C NMR (100 MHz, CDCl3) of compound 2a. 
 
Infrared spectrum (Thin Film, NaCl) of compound 2a. 
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 13C NMR (100 MHz, CDCl3) of compound 2b. 
 
Infrared spectrum (Thin Film, NaCl) of compound 2b. 
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 13C NMR (100 MHz, CDCl3) of compound 2c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 2c. 
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 13C NMR (100 MHz, CDCl3) of compound 2d. 
 
Infrared spectrum (Thin Film, NaCl) of compound 2d. 
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 13C NMR (100 MHz, CDCl3) of compound 2e. 
 
Infrared spectrum (Thin Film, NaCl) of compound 2e. 
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 13C NMR (100 MHz, CDCl3) of compound 2f. 
 
Infrared spectrum (Thin Film, NaCl) of compound 2f. 
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 13C NMR (100 MHz, CDCl3) of compound 2g. 
 
Infrared spectrum (Thin Film, NaCl) of compound 2g. 
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 19F NMR (282 MHz, CDCl3) of compound 2g. 
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 13C NMR (100 MHz, CDCl3) of compound 2h. 
 
Infrared spectrum (Thin Film, NaCl) of compound 2h. 
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 13C NMR (100 MHz, CDCl3) of compound 2i. 
 
Infrared spectrum (Thin Film, NaCl) of compound 2i. 
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 13C NMR (100 MHz, CDCl3) of compound 4. 
 
Infrared spectrum (Thin Film, NaCl) of compound 4. 
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 13C NMR (100 MHz, CD3OD) of compound 5. 
 
Infrared spectrum (Thin Film, NaCl) of compound 5. 
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 13C NMR (100 MHz, CDCl3) of compound 6. 
 
Infrared spectrum (Thin Film, NaCl) of compound 6. 
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 13C NMR (100 MHz, 50 ºC, CDCl3) of compound 7. 
 
Infrared spectrum (Thin Film, NaCl) of compound 7. 
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 13C NMR (100 MHz, CDCl3) of compound 8. 
 
Infrared spectrum (Thin Film, NaCl) of compound 8. 
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 13C NMR (100 MHz, CDCl3) of compound 9. 
 
Infrared spectrum (Thin Film, NaCl) of compound 9. 
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 19F NMR (100 MHz, CDCl3) of compound 9. 
 
